ESR2 and neoplasm: PD-L1–laIL-2 had a similar tumor control effect as Erb–laIL-2 or anti–PD-L1 (Figure 2D) and was far less effective than PD-1–laIL-2 (Figure 2E and Supplemental Figure 2C).